CRISPR THERAPEUTICS AG Depreciation
CRISPR THERAPEUTICS AG (CRSP) reported Depreciation of $4.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-03
- CRISPR THERAPEUTICS AG depreciation for the quarter ending 2026-06-30 was $4.30M, a 6.52% decline year-over-year.
- CRISPR THERAPEUTICS AG depreciation for the quarter ending 2026-03-31 was $4.30M, a 8.51% decline year-over-year.
- CRISPR THERAPEUTICS AG depreciation for the quarter ending 2025-12-31 was $5.60M, a 16.67% increase year-over-year.
- CRISPR THERAPEUTICS AG depreciation for the quarter ending 2025-09-30 was $4.40M, a 8.33% decline year-over-year.
- CRISPR THERAPEUTICS AG depreciation for fiscal 2025 was $19.40M, a 1.04% increase from fiscal 2024.
- CRISPR THERAPEUTICS AG depreciation for fiscal 2024 was $19.20M, a 3.03% decline from fiscal 2023.
- CRISPR THERAPEUTICS AG depreciation for fiscal 2023 was $19.80M, a 17.84% decline from fiscal 2022.
- CRISPR THERAPEUTICS AG depreciation for fiscal 2022 was $24.10M, a 34.64% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $4.30M 10-Q · filed 2026-08-03 | $8.60M 10-Q · filed 2026-08-03 | $14.20M derived: sum of 3 quarters · filed 2026-08-03 | $18.60M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2026-03-31 | $4.30M 10-Q · filed 2026-05-04 | $9.90M derived: sum of 2 quarters · filed 2026-05-04 | $14.30M derived: sum of 3 quarters · filed 2026-05-04 | $18.90M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $10.00M derived: sum of 2 quarters · filed 2026-02-12 | $14.60M derived: sum of 3 quarters · filed 2026-08-03 | $19.40M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $4.40M 10-Q · filed 2025-11-10 | $9.00M derived: sum of 2 quarters · filed 2026-08-03 | $13.80M 10-Q · filed 2025-11-10 | $18.50M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-06-30 | $4.60M 10-Q · filed 2026-08-03 | $9.30M 10-Q · filed 2026-08-03 | $14.10M derived: sum of 3 quarters · filed 2026-08-03 | $18.90M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $4.70M 10-Q · filed 2026-05-04 | $9.50M derived: sum of 2 quarters · filed 2026-05-04 | $14.30M derived: sum of 3 quarters · filed 2026-05-04 | $19.10M derived: sum of 4 quarters · filed 2026-05-04 | |
| 2024-12-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $9.60M derived: sum of 2 quarters · filed 2026-02-12 | $14.40M derived: sum of 3 quarters · filed 2026-02-12 | $19.20M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $4.80M 10-Q · filed 2025-11-10 | $9.60M derived: sum of 2 quarters · filed 2025-11-10 | $14.40M 10-Q · filed 2025-11-10 | $19.30M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-06-30 | $4.80M 10-Q · filed 2025-08-04 | $9.60M 10-Q · filed 2025-08-04 | $14.50M derived: sum of 3 quarters · filed 2026-02-12 | $19.40M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-03-31 | $4.80M 10-Q · filed 2025-05-06 | $9.70M derived: sum of 2 quarters · filed 2026-02-12 | $14.60M derived: sum of 3 quarters · filed 2026-02-12 | $19.60M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2023-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $9.80M derived: sum of 2 quarters · filed 2026-02-12 | $14.80M derived: sum of 3 quarters · filed 2026-02-12 | $19.80M 10-K · filed 2026-02-12 | |
| 2023-09-30 | $4.90M 10-Q · filed 2024-11-05 | $9.90M derived: sum of 2 quarters · filed 2024-11-05 | $14.90M 10-Q · filed 2024-11-05 | $20.70M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-06-30 | $5.00M 10-Q · filed 2024-08-05 | $10.00M 10-Q · filed 2024-08-05 | $15.80M derived: sum of 3 quarters · filed 2025-02-11 | $20.80M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-08 | $10.80M derived: sum of 2 quarters · filed 2025-02-11 | $15.80M derived: sum of 3 quarters · filed 2025-02-11 | $23.10M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2022-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $10.80M derived: sum of 2 quarters · filed 2025-02-11 | $18.10M derived: sum of 3 quarters · filed 2025-02-11 | $24.10M 10-K · filed 2025-02-11 | |
| 2022-09-30 | $5.00M 10-Q · filed 2023-11-06 | $12.30M derived: sum of 2 quarters · filed 2023-11-06 | $18.30M 10-Q · filed 2023-11-06 | $24.50M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $7.30M 10-Q · filed 2023-08-07 | $13.30M 10-Q · filed 2023-08-07 | $19.50M derived: sum of 3 quarters · filed 2024-02-21 | $24.80M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $6.00M 10-Q · filed 2023-05-08 | $12.20M derived: sum of 2 quarters · filed 2024-02-21 | $17.50M derived: sum of 3 quarters · filed 2024-02-21 | $21.10M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $11.50M derived: sum of 2 quarters · filed 2024-02-21 | $15.10M derived: sum of 3 quarters · filed 2024-02-21 | $17.90M 10-K · filed 2024-02-21 | |
| 2021-09-30 | $5.30M 10-Q · filed 2022-11-01 | $8.90M derived: sum of 2 quarters · filed 2022-11-01 | $11.70M 10-Q · filed 2022-11-01 | $14.10M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | $3.60M 10-Q · filed 2022-08-08 | $6.30M 10-Q · filed 2022-08-08 | $8.80M derived: sum of 3 quarters · filed 2023-02-21 | $11.10M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-31 | $2.70M 10-Q · filed 2022-05-09 | $5.20M derived: sum of 2 quarters · filed 2023-02-21 | $7.50M derived: sum of 3 quarters · filed 2023-02-21 | $9.70M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $4.80M derived: sum of 2 quarters · filed 2023-02-21 | $7.00M derived: sum of 3 quarters · filed 2023-02-21 | $9.10M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $2.30M 10-Q · filed 2021-11-03 | $4.50M derived: sum of 2 quarters · filed 2021-11-03 | $6.60M 10-Q · filed 2021-11-03 | $8.00M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-06-30 | $2.20M 10-Q · filed 2021-07-29 | $4.30M 10-Q · filed 2021-07-29 | $5.70M derived: sum of 3 quarters · filed 2022-02-15 | $7.00M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-03-31 | $2.10M 10-Q · filed 2021-04-27 | $3.50M derived: sum of 2 quarters · filed 2022-02-15 | $4.80M derived: sum of 3 quarters · filed 2022-02-15 | $5.80M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2019-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $2.70M derived: sum of 2 quarters · filed 2022-02-15 | $3.70M derived: sum of 3 quarters · filed 2022-02-15 | $4.70M 10-K · filed 2022-02-15 | |
| 2019-09-30 | $1.30M 10-Q · filed 2020-10-28 | $2.30M derived: sum of 2 quarters · filed 2020-10-28 | $3.30M 10-Q · filed 2020-10-28 | $4.20M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-06-30 | $1.00M 10-Q · filed 2020-07-27 | $2.00M 10-Q · filed 2020-07-27 | $2.90M derived: sum of 3 quarters · filed 2021-02-16 | $3.70M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-03-31 | $1.00M 10-Q · filed 2020-04-28 | $1.90M derived: sum of 2 quarters · filed 2021-02-16 | $2.70M derived: sum of 3 quarters · filed 2021-02-16 | $3.60M derived: sum of 4 quarters · filed 2021-02-16 | |
| 2018-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $1.70M derived: sum of 2 quarters · filed 2021-02-16 | $2.60M derived: sum of 3 quarters · filed 2021-02-16 | $3.50M 10-K · filed 2021-02-16 | |
| 2018-09-30 | $800.00K 10-Q · filed 2019-10-28 | $1.70M derived: sum of 2 quarters · filed 2019-10-28 | $2.60M 10-Q · filed 2019-10-28 | $2.50M 10-Q · filed 2018-11-07 | $3.30M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $900.00K 10-Q · filed 2019-07-29 | $1.70M 10-Q · filed 2019-07-29 | $2.50M derived: sum of 3 quarters · filed 2020-02-12 | $3.30M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-03-31 | $800.00K 10-Q · filed 2019-04-29 | $1.60M derived: sum of 2 quarters · filed 2020-02-12 | $2.40M derived: sum of 3 quarters · filed 2020-02-12 | $3.10M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2017-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $1.60M derived: sum of 2 quarters · filed 2020-02-12 | $2.30M derived: sum of 3 quarters · filed 2020-02-12 | $3.00M 10-K · filed 2020-02-12 | |
| 2017-09-30 | $800.00K 10-Q · filed 2018-11-07 | $1.50M derived: sum of 2 quarters · filed 2018-11-07 | $2.20M 10-Q · filed 2018-11-07 | $2.60M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-06-30 | $700.00K 10-Q · filed 2018-08-07 | $1.40M 10-Q · filed 2018-08-07 | $1.80M derived: sum of 3 quarters · filed 2019-02-25 | $2.00M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-03-31 | $700.00K 10-Q · filed 2018-05-08 | $1.10M derived: sum of 2 quarters · filed 2019-02-25 | $1.30M derived: sum of 3 quarters · filed 2019-02-25 | $1.40M derived: sum of 4 quarters · filed 2019-02-25 | |
| 2016-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $600.00K derived: sum of 2 quarters · filed 2019-02-25 | $700.00K derived: sum of 3 quarters · filed 2019-02-25 | $900.00K 10-K · filed 2019-02-25 | |
| 2016-09-30 | $200.00K 10-Q · filed 2017-11-08 | $300.00K derived: sum of 2 quarters · filed 2017-11-08 | $500.00K 10-Q · filed 2017-11-08 | $473.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | $100.00K 10-Q · filed 2017-08-10 | $200.00K 10-Q · filed 2017-08-10 | $273.00K derived: sum of 3 quarters · filed 2018-03-08 | $300.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-03-31 | $100.00K 10-Q · filed 2017-05-11 | $173.00K derived: sum of 2 quarters · filed 2018-03-08 | $200.00K derived: sum of 3 quarters · filed 2018-03-08 | ||
| 2015-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $100.00K derived: sum of 2 quarters · filed 2018-03-08 | $100.00K 10-K · filed 2018-03-08 | ||
| 2015-09-30 | $27.00K 10-Q · filed 2016-11-22 | $27.00K 10-Q · filed 2016-11-22 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |